Sequella Overview

Sequella Acquires Exclusive Worldwide Rights to Pfizers Sutezolid, Currently in Clinical Development for Tuberculosis. Sequellas Lead Antitubercular Drug Candidate SQ109 Begins Phase 2b Clinical Trial in Africa. Maxwell Biotech Venture Funds Portfolio Company, Infectex, Enrolls First Multi-Drug Resistant Tuberculosis MDR-TB Patients in Pivotal Clinical Trial of SQ109, Licensed from Sequella. Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing i.

OVERVIEW

The website sequella.com currently has an average traffic classification of zero (the lower the more users). We have crawled six pages within the site sequella.com and found ten websites interfacing with sequella.com. There is three contacts and directions for sequella.com to help you communicate with them. The website sequella.com has been on the internet for one thousand four hundred and one weeks, six days, two hours, and nineteen minutes.
Pages Parsed
6
Links to this site
10
Contacts
3
Addresses
3
Online Since
Dec 1997

SEQUELLA.COM TRAFFIC

The website sequella.com has seen alternating quantities of traffic for the duration of the year.
Traffic for sequella.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for sequella.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for sequella.com

Date Range

All time
This Year
Last Year
Last Month

SEQUELLA.COM HISTORY

The website sequella.com was registered on December 05, 1997. This website was updated on the date of August 15, 2011. It will expire on the date of December 04, 2016. As of today, it is one thousand four hundred and one weeks, six days, two hours, and nineteen minutes young.
REGISTERED
December
1997
UPDATED
August
2011
EXPIRED
December
2016

AGE

26
YEARS
10
MONTHS
5
DAYS

LINKS TO SEQUELLA.COM

Breast Cancer Start-up Challenge - Breast Cancer Startup Challenge Home Page

1 Diagnostic from biopsies with software analysis. 2 Immunotherapy Using Modified Self Tumor Cells. 3 Combination of Tissue Reconstruction and Recurrence Prevention. 4 Human monoclonal Antibody Based Cancer Therapies. 5 Immunotherapy Using Granulysin Activated Monocytes. 7 Versatile Delivery Method for Cancer Therapeutics. 8 Genomic Based Diagnostic Assay. 10 Diagnostic Kit for Therapy Benefit Prediction.

Lung Diseases

Publié par Benjamin de Bélizal.

Maxwell Biotech Group MBG

Maxwell Biotech Group currently has 9 biotech companies in its portfolio, which are engaged in the development of 11 innovative clinical stage drugs.

WHAT DOES SEQUELLA.COM LOOK LIKE?

Desktop Screenshot of sequella.com Mobile Screenshot of sequella.com Tablet Screenshot of sequella.com

CONTACTS

Sequella

9610 Medical Center Drive, Suite 200

Rockville, MD, 20850

US

Sequella

Horwith, Gary

9610 Medical Center Dr

Rockville, MD, 20850

US

Stickdog Telecom, Inc.

Stickdog Telecom, Inc.

143A CHURCH ST

VIENNA, VA, 22180

US

SEQUELLA.COM SERVER

I discovered that a lone root page on sequella.com took one hundred and fifty-six milliseconds to load. Our web crawlers could not find a SSL certificate, so in conclusion our crawlers consider this site not secure.
Load time
0.156 sec
SSL
NOT SECURE
IP
206.188.192.194

NAME SERVERS

ns43.worldnic.com
ns44.worldnic.com

SERVER SOFTWARE

We identified that this website is employing the Apache/2.2.29 (Unix) FrontPage/5.0.2.2635 os.

SITE TITLE

Sequella Overview

DESCRIPTION

Sequella Acquires Exclusive Worldwide Rights to Pfizers Sutezolid, Currently in Clinical Development for Tuberculosis. Sequellas Lead Antitubercular Drug Candidate SQ109 Begins Phase 2b Clinical Trial in Africa. Maxwell Biotech Venture Funds Portfolio Company, Infectex, Enrolls First Multi-Drug Resistant Tuberculosis MDR-TB Patients in Pivotal Clinical Trial of SQ109, Licensed from Sequella. Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing i.

PARSED CONTENT

The website sequella.com has the following in the web site, "Sequella Acquires Exclusive Worldwide Rights to Pfizers Sutezolid, Currently in Clinical Development for Tuberculosis." I analyzed that the website also stated " Sequellas Lead Antitubercular Drug Candidate SQ109 Begins Phase 2b Clinical Trial in Africa." They also stated " Maxwell Biotech Venture Funds Portfolio Company, Infectex, Enrolls First Multi-Drug Resistant Tuberculosis MDR-TB Patients in Pivotal Clinical Trial of SQ109, Licensed from Sequella. Sequella is a clinical stage antiinfectives company focused on discovering, developing, and commercializing i."

SEE OTHER WEBSITES

sequelle Stamps Stocks - DeviantArt

Where Stamp Makers Unite! Deviant for 7 Years. Deviant since Jul 14, 2008.

SeQuelle93 Martyna - DeviantArt

Forgot Password or Username? Deviant for 7 Years. This is the place where you can personalize your profile! By moving, adding and personalizing widgets.

Tech trends and business ideas

All things that motivate entrepreneurs. Tuesday, July 24, 2012. Exactly what Infosys must be doing with its cash hoard! Instead of grumbling about client indecision on discretionary tech spends or reminding doubting analysts about its choice for marathon over sprint. Indian outsourcing vendors like Infosys must be focusing on acquiring smart startups like NICIRA that VMware is seeking out to buy giving it a massive leap in its technology focus. Shibulal, are you listening? .

Sequel - sister to sequel magazine

Introduction to Creative Writing students chose one word from the dictionary, at random. Then, created their own interpretive definition, as free verse. Good May, my sweet followers! To commemorate this transformation, our Committee of Enterprise will be hosting a potluck gathering in Washington D.

Certified EHR Vendor, Practice Management SoftwareSequelMed, NY

SequelMed Medical Billing Software is built from the ground up to cater the needs of Medical Billing companies. ONC Offers EHR Interoperability Training. Connected EHRs and MU2 transition of care measures. Switching EHR vendor for all the right reasons.